Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab
在接受英夫利昔单抗和维多珠单抗治疗的炎症性肠病患者中，接种两剂SARS-CoV-2疫苗后抗体衰减、T细胞免疫和突破性感染的情况
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-022-28517-z
Lin, Simeng; Kennedy, Nicholas A; Saifuddin, Aamir; Sandoval, Diana Muñoz; Reynolds, Catherine J; Seoane, Rocio Castro; Kottoor, Sherine H; Pieper, Franziska P; Lin, Kai-Min; Butler, David K; Chanchlani, Neil; Nice, Rachel; Chee, Desmond; Bewshea, Claire; Janjua, Malik; McDonald, Timothy J; Sebastian, Shaji; Alexander, James L; Constable, Laura; Lee, James C; Murray, Charles D; Hart, Ailsa L; Irving, Peter M; Jones, Gareth-Rhys; Kok, Klaartje B; Lamb, Christopher A; Lees, Charlie W; Altmann, Daniel M; Boyton, Rosemary J; Goodhand, James R; Powell, Nick; Ahmad, Tariq
SARS-CoV-2
炎症
T细胞
炎症/感染
T细胞
细胞生物学
免疫/内分泌
